ホーム > 市場調査レポート > 医薬品 > 動物用医薬 > 動物用寄生虫駆除剤市場の現状と今後の展望
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

動物用寄生虫駆除剤市場の現状と今後の展望

Antiparasitics in the Animal Health Industry: Current markets and future prospects

発行 PJB Publications Ltd.
出版日 2005年05月 商品コード 29622
ページ情報 英文  
価格
こちらの商品の販売は終了いたしました。

当商品の販売は、2011年07月19日を持ちまして終了しました。

原文目次

Abstract

Features national market profiles, market sizes and market forecasts to 2009

Successful new antiparasitics have driven growth in the animal health industry over the last decade, but many of the best sellers are now coming off-patent. How will this key market develop over the next few years - will its value be eroded by price competition amongst generic producers, or will new products, new formulations and new delivery technologies continue to boost the market?

This Animal Pharm report answers all your questions on this $4.7 billion market. It features:

  • Detailed analyses of the leading 10 national markets, including market forecasts to 2009
  • Profiles of the leading companies in the sector
  • Profiles of the leading antiparasitics on the market
  • A review of the most commercially important parasites

Key findings

  • Double digit growth in 2004 saw pet flea/tick product sales reach $1,025 million in the US, boosted by the combination products Frontline Plus (with sales close to $300 million) and Advantage/ Advantix (with sales approaching $200 million)
  • The worlds best-selling antiparasitics are Merials Frontline, with sales of $679 million in 2004, and Bayers Advantage, with sales of $225 million
  • The Brazilian antiparasitics market is forecast to grow at the highest rate over the next five years, with a CAGR of 8% taking the market to $301 million by 2009
  • France is the second largest national market, with 2004 sales of ?224 million ($278 million), ?75 million ($93 million) of which were flea/tick treatments
  • In Australia in 2004, sales of large animal endoparasiticides were Aus$92 million (US$68 million), whilst endectocides reached Aus$57 million (US$42 million)

Table of Contents

1 Major livestock and companion animal parasites
2 Antiparasitic products
3 The market for antiparasitic products
4 Company profiles
Back to Top